Adults With Overweight/Obesity and Type 2 Diabetes Clinical Trials in Tampa, Florida

A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity